You are invited to submit abstracts for the Eighth Annual Clinical Congress to be held in Riyadh, KSA during the period of November 5-7, 2020.

Depending on the number of submitted abstracts and their quality, the abstracts will be selected for either platform or for poster presentation. All accepted abstracts will be distributed in the congress abstract book.Only abstracts that contain original data can be submitted. Review topics will not be accepted.

Abstracts submissions are possible until August 15th, 2020 (18:00 Dubai time +4 GMT). Abstracts can be re-edited and modified until the submission deadline. Any abstract received after the deadline will not be accepted. Upon completion of evaluation an ‘Accepted’ or ‘Rejected’ email will be sent to each application submitted. The result of the evaluation will be send approximately 14 days after deadline submission.

The corresponding author has the right to grant, on behalf of all authors an exclusive license to the editor of JDEP to  publish the abstract (if accepted) in the Journal.

All abstracts accepted will be published in the Journal of Diabetes and Endocrine Practice


  • Diabetes
  • Disorders of Sex Differentiation
  • Disorders of the Adrenal Gland
  • Calcium and Bone Health
  • Genetic Endocrinology
  • Education in Pediatric Endocrinology and Diabetes
  • Disorders of Glucose metabolism
  • Disorders of Lipid metabolism
  • Obesity and related complications
  • Growth disorders
  • Disorders of the Pituitary Gland
  • Disorders of Puberty
  • Thyroid Disorders




  • All submitted abstracts must be in English


  • The content of the abstract is solely the responsibility of the author. The original abstract is reprinted exactly as provided. During submission, it must clearly indicate the name of the presenting author, who will be considered the contact person for all correspondence connected with the submitted abstract.
  • All submitted abstracts need to have the names and surnames of all co-authors, along with their positions in their affiliated institutions.
  • The presenting author can be any of the listed authors without affiliations to industry.


  • Poster & Oral submissions need to be limited to 300 words.


  • An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. It is encouraged that the title is set so as to attract the audience and to hint to the conclusion of the investigation.


  • A well-written abstract typically has the following identified sections:
    1. Background/objectives: a brief introduction, which states the problem that you are addressing as well as some background information on the issue. The introduction of the abstract should include a very brief background 1-2 statements followed by the objectives of the investigation.
    2. Design and methods: the methodologies, number of test subjects and scientific approach used to conduct the research.
    3. Results: it is expected that authors present data that support their conclusion. Tables and graphs should include explanatory captions.
    4. Conclusions: further areas of research and overall conclusion of the research
    5. Citation: a reference list and acknowledgements, if applicable. A maximum of two tables/graphs/images can be included.


It is the intent of AACE Gulf Chapter to provide high quality sessions focused on educational content that is free from commercial influence or bias.

A disclosure form identifying commercial relationships or conflict of interest for all co-authors must be completed by the submitting author, if their abstract has been accepted for publication. The submitting author signs and verifies disclosure on behalf of all co-authors. Disclosure information for accepted abstracts will be made available to the congress attendees.

Abstracts should not be submitted if the following applies:

  • The abstract contains data that has been published or accepted for publication in a print or online journal.
  • The abstract contains data that was presented at a scientific meeting less than 6 months prior to AACE, GC 2020

All authors should refrain from submitting Pharma Abstracts.


The submitting author must verify that all co-authors have read and approved the submission of the abstract.


Abstracts will be reviewed blinded without the names of submitting authors appearing to the reviewers.

The reviewers will    judge the abstracts according to the scientific or clinical value, relevance to AACE GC, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.

Upon completion of the evaluation of submitted abstracts, an ‘Accepted’ or ‘Rejected’ email will be sent to authors. Abstract acceptance will be in one of two categories: oral presentation or poster presentation. Upon acceptance of an author’s submission, the following instructions below are applicable:

  • The presenting author of the presentation should confirm their attendance upon receiving the acceptance email within one week.
  • The availability of any sort of grant for registration, travel and/or accommodation will be mentioned in the acceptance email, without any guarantees at the abstract submission stage.
  • Accepted authors will receive one complimentary registration pass that will be assigned and sent up to 10 days prior to the congress
  • Authors who confirm presence will receive a free communication code based on their category of submission up to 10 days before the congress.
  • If you need to withdraw your abstract, a written statement listing the reasons for this decision must be sent to the abstract helpdesk at science@medgress.com no later than August 15, 2020
  • Travel bursary application: Opening: 20 September 2020, Deadline: 30 September 2020
  • Upon abstract submission, oral abstracts presenting authors may apply for travel bursary.
  • Only presenting authors are entitled to apply for a travel bursary.